Europe

DenovoMatrix binds funding
TU Dresden spinout DenovoMatrix hopes to commercialise a method for effectively cultivating stem cell production.
Threatray registers seed funding
Newly-launched Bern University of Applied Sciences spinout Threatray believes its automated malware detection design will improve upon existing approaches.
Kets Quantum secures $2.5m
Bristol quantum computer security spinout Kets Quantum Security has won investment from Kx Systems after joining the corporate-backed Teac communications accelerator last year.
UCL eyes $126m second fund
University College London hopes to generate as much as $126m for its second Technology Fund, with British Business Bank thought to be among potential limited partners.
Robert Gordon primes accelerator
A total of 28 participants will receive up to $12,650 of capital to support business proposals in spaces including healthcare, fintech, fashion and retail.
Istesso stakes $7.6m
IP Group has poured more funding into Istesso, whose treatment for rheumatoid arthritis traces its roots to an Aberdeen spinout, to drive immuno-metabolism therapies for autoimmune diseases.
10X Genomics picks up Spatial Transcriptomics
10X Genomics has purchased genomic analysis platform Spatial Transcriptomics, based on research at Karolinska Institute and KTH Royal Institute of Technology.
Parakey unlocks $1m
Chalmers Ventures has again supplied smart lock supplier Parakey with funding after investing alongside IoT and wireless tech firm Qamcom in 2016.

Other News

Lund launches Asgard Therapeutics
Asgard Therapeutics will develop cancer therapies which use reprogrammed human skin cells to improve the immune system’s capacity to identify cancerous particles.
WaveOptics makes a splash with $26m
IP Group has backed AR technology developer WaveOptics, building on the position taken by Touchstone Innovations, which it now owns, in 2015 and 2017.
Genomics encounters $42m series B
Foresite Capital and F-Prime Capital joined earlier series B investors including Oxford Science Innovations to take Oxford drug discovery spinout Genomics’ total funding to $58.2m.
Evox visits Gates Foundation for funding
Oxford drug delivery spinout Evox Therapeutics collected funding from Bill and Melinda Gates Foundation in its bid to engineer exosome delivery vessels for a range of drugs.
Bios signals for $4.5m
Cambridge neural interface spinout Bios will use some of the seed capital to develop an interface between prosthetic objects and the human nervous system.
Oxford excavates PalaeoPi
PalaeoPi, which began operations almost a year ago, is developing a photogrammetry-powered 3D scanner called MKIII TablePi for purposes including archaeology.

Editor's Picks

Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Opportunities and challenges abound at PraxisAuril conference
PraxisAuril's spring conference continues to go from strength to strength, with one in three delegates a first-time attendant.
test reg

Login